<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicines (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Medicines (Basel)</journal-id><journal-id journal-id-type="publisher-id">medicines</journal-id><journal-title-group><journal-title>Medicines</journal-title></journal-title-group><issn pub-type="epub">2305-6320</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6163473</article-id><article-id pub-id-type="doi">10.3390/medicines5030061</article-id><article-id pub-id-type="publisher-id">medicines-05-00061</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antibacterial, Antioxidant, and Antiproliferative Activities of <italic>Corymbia citriodora</italic> and the Essential Oils of Eight <italic>Eucalyptus</italic> Species</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2507-4228</contrib-id><name><surname>Miguel</surname><given-names>Maria Gra&#x000e7;a</given-names></name><xref ref-type="aff" rid="af1-medicines-05-00061">1</xref><xref rid="c1-medicines-05-00061" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Gago</surname><given-names>Cust&#x000f3;dia</given-names></name><xref ref-type="aff" rid="af2-medicines-05-00061">2</xref></contrib><contrib contrib-type="author"><name><surname>Antunes</surname><given-names>Maria Dulce</given-names></name><xref ref-type="aff" rid="af3-medicines-05-00061">3</xref></contrib><contrib contrib-type="author"><name><surname>Lagoas</surname><given-names>Soraia</given-names></name><xref ref-type="aff" rid="af4-medicines-05-00061">4</xref></contrib><contrib contrib-type="author"><name><surname>Faleiro</surname><given-names>Maria Leonor</given-names></name><xref ref-type="aff" rid="af4-medicines-05-00061">4</xref></contrib><contrib contrib-type="author"><name><surname>Meg&#x000ed;as</surname><given-names>Cristina</given-names></name><xref ref-type="aff" rid="af5-medicines-05-00061">5</xref></contrib><contrib contrib-type="author"><name><surname>Cort&#x000e9;s-Giraldo</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="af5-medicines-05-00061">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0109-0584</contrib-id><name><surname>Vioque</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="af5-medicines-05-00061">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3239-3190</contrib-id><name><surname>Figueiredo</surname><given-names>Ana Cristina</given-names></name><xref ref-type="aff" rid="af6-medicines-05-00061">6</xref></contrib></contrib-group><aff id="af1-medicines-05-00061"><label>1</label>Departamento de Qu&#x000ed;mica e Farm&#x000e1;cia, Faculdade de Ci&#x000ea;ncias e Tecnologia, Universidade do Algarve, MeditBio, Campus de Gambelas, 8005-139 Faro, Portugal</aff><aff id="af2-medicines-05-00061"><label>2</label>MeditBio, Faculdade de Ci&#x000ea;ncias e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Portugal; <email>cgago@ualg.pt</email></aff><aff id="af3-medicines-05-00061"><label>3</label>CEOT/MeditBio Faculdade de Ci&#x000ea;ncias e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Potugal; <email>mantunes@ualg.pt</email></aff><aff id="af4-medicines-05-00061"><label>4</label>Centre for Biomedical Research (CBMR), Faculdade de Ci&#x000ea;ncias e Tecnologia, Universidade do Algarve, Campus de Gambelas, 8005-139 Faro, Potugal; <email>soraia_s_s@hotmail.com</email> (S.L.); <email>mfaleiro@ualg.pt</email> (M.L.F.)</aff><aff id="af5-medicines-05-00061"><label>5</label>Instituto de la Grasa (C.S.I.C.), Universidad Pablo de Olavide, Edificio 46, Carretera de Utrera, km 1, 41013 Sevilla, Spain; <email>cmegias@cica.es</email> (C.M.); <email>icortes@ig.csic.es</email> (I.C.-G.); <email>jvioque@cica.es</email> (J.V.)</aff><aff id="af6-medicines-05-00061"><label>6</label>Centro de Estudos do Ambiente e do Mar (CESAM Lisboa), Faculdade de Ci&#x000ea;ncias da Universidade de Lisboa, Centro de Biotecnologia Vegetal (CBV), DBV, C2, Campo Grande, 1749-016 Lisboa, Portugal; <email>acsf@fc.ul.pt</email></aff><author-notes><corresp id="c1-medicines-05-00061"><label>*</label>Correspondence: <email>mgmiguel@ualg.pt</email>; Tel.: +351-289-800-100</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>6</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2018</year></pub-date><volume>5</volume><issue>3</issue><elocation-id>61</elocation-id><history><date date-type="received"><day>16</day><month>5</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background:</bold> Essential oils (EOs) have shown antimicrobial, antioxidant, and antiproliferative activity, which may, alone or in combination with other substances, potentially be used for the development of new drugs. However, their chemical variability, depending on the species, varieties, or geographical origin (among other factors) determines different bioactivities that need to be evaluated. <bold>Methods:</bold> The antioxidant activity of <italic>Corymbia citriodora</italic> and eight <italic>Eucalyptus</italic> species EOs was determined using two different methods: the scavenging ability of 2,2&#x02032;-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS<sup>+&#x02022;</sup>) and peroxyl free radicals or oxygen radical absorbance capacity (ORAC). Antibacterial activity was evaluated using the microorganisms <italic>Streptococcus pneumoniae</italic> (strains D39 and TIGR4), and <italic>Haemophilus influenza</italic> (strain DSM 9999). The essential oils&#x02019; minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) was assessed using a microdilution method. The antiproliferative activity was determined using the THP-1 cell line (human acute monocytic leukaemia) with methylthiazolyldiphenyl-tetrazolium bromide assay (MTT). <bold>Results:</bold>
<italic>Corymbia citriodora</italic> and <italic>Eucalyptus viminalis</italic> EOs showed the highest ABTS and peroxyl free radical scavenging capacity. <italic>Eucalyptus globulus</italic> EO showed a high potential to treat <italic>Streptococcus pneumoniae</italic> infections. <italic>Haemophilus influenzae</italic> was the respiratory pathogen that showed the highest resistance to all EOs, including tea tree EO. After 96 h of incubation, at 25 &#x003bc;g/mL, <italic>Eucalyptus radiata</italic> and <italic>Eucalyptus viminalis</italic> EOs showed highest cytotoxic activity against the THP-1 cell line. <bold>Conclusions:</bold> Despite their specific bioactivities, no single EO showed simultaneously good antioxidant, antimicrobial, and antiproliferative activity.</p></abstract><kwd-group><kwd><italic>Corymbia citriodora</italic></kwd><kwd><italic>Eucalyptus dives</italic></kwd><kwd><italic>Eucalyptus globulus</italic></kwd><kwd><italic>Eucalyptus delegatensis</italic> subsp. tasmaniensis</kwd><kwd><italic>Eucalyptus pauciflora</italic></kwd><kwd><italic>Eucalyptus radiata</italic></kwd><kwd><italic>Eucalyptus smithii</italic></kwd><kwd><italic>Eucalyptus urophylla</italic></kwd><kwd><italic>Eucalyptus viminalis</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-medicines-05-00061"><title>1. Introduction</title><p><italic>Streptococcus pneumoniae</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Haemophilus influenzae</italic> may asymptomatically colonize the upper respiratory tract and are the etiologic agents of acute otitis media, sinusitis, and pneumonia. <italic>S. pneumoniae</italic> is also responsible for bacterial meningitis [<xref rid="B1-medicines-05-00061" ref-type="bibr">1</xref>,<xref rid="B2-medicines-05-00061" ref-type="bibr">2</xref>]. Nowadays, the treatment of these diseases is threatened by the development of antibiotic resistance worldwide [<xref rid="B3-medicines-05-00061" ref-type="bibr">3</xref>]. Essential oils (EOs) and their isolated compounds have been shown to possess antimicrobial activity against several pathogens [<xref rid="B4-medicines-05-00061" ref-type="bibr">4</xref>]. The complex mixtures that generally constitute EOs can be advantageous because pathogens have difficulty in displaying resistance mechanisms to the multiple constituents of essential oils [<xref rid="B5-medicines-05-00061" ref-type="bibr">5</xref>,<xref rid="B6-medicines-05-00061" ref-type="bibr">6</xref>].</p><p>Reactive oxygen species (ROS) have a physiological role in normal cell function, but when their production exceeds their elimination, an excess of ROS in the body occurs and consequently, diseases also arise because ROS can damage important biomolecules [<xref rid="B7-medicines-05-00061" ref-type="bibr">7</xref>]. Damage of nucleic acids may trigger cancer development. In general, it is considered that the use of antioxidants prevents or retards the appearance of diverse diseases, including cancer, although le Gal et al. [<xref rid="B8-medicines-05-00061" ref-type="bibr">8</xref>] reported that increased intracellular antioxidant activity may induce tumour cell survival. EOs have been demonstrated to possess antioxidant and antiproliferative properties which may contribute to the development of new chemotherapeutic drugs in the future [<xref rid="B9-medicines-05-00061" ref-type="bibr">9</xref>].</p><p>The Myrtaceae eucalyptus group comprises four genera: <italic>Angophora</italic> Cav., <italic>Arillastrum</italic> (Brongniart &#x00026; Gris) Pancher ex Baillon, <italic>Corymbia</italic> K. D. Hill &#x00026; L.A.S. Johnson, and <italic>Eucalyptus</italic> L&#x02019;Herit [<xref rid="B10-medicines-05-00061" ref-type="bibr">10</xref>,<xref rid="B11-medicines-05-00061" ref-type="bibr">11</xref>]. Despite this classification, it is common to designate as <italic>Eucalyptus</italic> several species of the four genera [<xref rid="B12-medicines-05-00061" ref-type="bibr">12</xref>]. The eucalyptus group includes around 900 species and subspecies (Brooker and Kleinig in [<xref rid="B13-medicines-05-00061" ref-type="bibr">13</xref>]). Species of the genus <italic>Eucalyptus</italic> are well adapted to diverse edaphoclimatic conditions, show rapid growth, and are easy to cultivate. Hence the genus <italic>Eucalyptus</italic>, originally from Australia, is widespread all over the world. <italic>Eucalyptus</italic> is mainly cultivated for obtaining cellulose, wood, gum, and EOs. The latter is obtained from the leaves and used in medicine, perfumery, and the food industry [<xref rid="B14-medicines-05-00061" ref-type="bibr">14</xref>].</p><p>The recent compilation by Dhakad et al. [<xref rid="B15-medicines-05-00061" ref-type="bibr">15</xref>] shows that <italic>Eucalyptus</italic> spp. leaf EOs possess biological and pharmacological properties, namely antimicrobial, antidiabetic, anthelmintic, antiviral, antihistaminic, anti-inflammatory, antimalarial, antioxidant, cytotoxic, larvicidal, nerve blocking, and pain-relieving activity, and are also useful for the relief of respiratory diseases and for wound healing. <italic>Eucalyptus</italic> EOs also possess activities as insecticides, pesticides, and nematicides [<xref rid="B15-medicines-05-00061" ref-type="bibr">15</xref>,<xref rid="B16-medicines-05-00061" ref-type="bibr">16</xref>,<xref rid="B17-medicines-05-00061" ref-type="bibr">17</xref>].</p><p><italic>Eucalyptus</italic> leaf essential oils are usually dominated by monoterpenes and sesquiterpenes. Nevertheless, their relative amounts or the ratio between them may differ according to species and varieties. Even within the same variety, the chemical composition may change depending on the geographical origin [<xref rid="B12-medicines-05-00061" ref-type="bibr">12</xref>]. This highlights the importance of the knowledge of chemical composition since it will determine the bioactivity of each EO.</p><p>In the present work, the antioxidant, antimicrobial, and antiproliferative activities of EOs from <italic>Corymbia citriodora</italic>, <italic>Eucalyptus dives</italic>, <italic>Eucalyptus globulus</italic>, <italic>Eucalyptus delegatensis</italic> subsp. <italic>tasmaniensis</italic>, <italic>Eucalyptus pauciflora</italic>, <italic>Eucalyptus radiata</italic>, <italic>Eucalyptus smithii</italic>, <italic>Eucalyptus urophylla</italic>, and <italic>Eucalyptus viminalis</italic> (all from Portugal) were evaluated.</p></sec><sec id="sec2-medicines-05-00061"><title>2. Materials and Methods</title><sec id="sec2dot1-medicines-05-00061"><title>2.1. Plant Material, EO Extraction, and Composition Analysis</title><p>EOs were isolated from fresh aerial parts, collected during the vegetative phase in Portugal (<xref rid="medicines-05-00061-t001" ref-type="table">Table 1</xref>), and their composition determined as previously described [<xref rid="B18-medicines-05-00061" ref-type="bibr">18</xref>].</p><sec id="sec2dot1dot1-medicines-05-00061"><title>2.1.1. Isolation of the Essential Oils </title><p>The essential oils were isolated by hydrodistillation for 3 h using a Clevenger-type apparatus according to the European Pharmacopoeia method [<xref rid="B19-medicines-05-00061" ref-type="bibr">19</xref>]. The isolation procedure was run at a distillation rate of 3 mL/min, and the essential oils were stored at &#x02212;20 &#x000b0;C in the dark until analysis.</p></sec><sec id="sec2dot1dot2-medicines-05-00061"><title>2.1.2. Gas Chromatography (GC) </title><p>Gas chromatographic analyses were performed using a Perkin Elmer Autosystem XL gas chromatograph (Perkin Elmer, Shelton, CT, USA) equipped with two flame ionization detectors (FIDs), a data handling system, and a vaporizing injector port into which two columns of different polarities were installed: a DB-1 fused-silica column (100% dimethylpolysiloxane, 30 m &#x000d7; 0.25 mm i.d., film thickness 0.25 &#x003bc;m; J &#x00026; W Scientific Inc., Folsom, CA, USA) and a DB-17HT fused-silica column ((50%-phenyl)-methylpolysiloxane, 30 m &#x000d7; 0.25 mm i.d., film thickness 0.15 &#x003bc;m; J &#x00026; W Scientific Inc.). The oven temperature was programmed to 45&#x02013;175 &#x000b0;C, increasing at 3 &#x000b0;C/min, subsequently increased to 300 &#x000b0;C at to 15 &#x000b0;C/min, and then maintained isothermal for 10 min; injector and detector temperatures were 280 &#x000b0;C and 300 &#x000b0;C, respectively. The carrier gas, hydrogen, was adjusted to a linear velocity of 30 cm/s. The samples were injected using a split sampling technique, ratio 1:50. The volume of injection was 0.1 &#x003bc;L of a distilled <italic>n</italic>-pentane-oil solution (1:1). The percentage composition of the oils was computed by the normalization method from the GC peak areas, calculated as a mean value of two injections from each oil, without response factors.</p></sec><sec id="sec2dot1dot3-medicines-05-00061"><title>2.1.3. Gas Chromatography-Mass Spectrometry (GC-MS)</title><p>The GC-MS unit consisted of a Perkin Elmer Autosystem XL gas chromatograph, equipped with DB-1 fused-silica column (30 m &#x000d7; 0.25 mm i.d., film thickness 0.25 &#x003bc;m; J &#x00026; W Scientific, Inc.), and interfaced with Perkin-Elmer Turbomass mass spectrometer (software version 5.4.2.1617, PerkinElmer, Shelton, CT, USA). Injector and oven temperatures were as above; transfer line temperature, 280 &#x000b0;C; ion source temperature, 220 &#x000b0;C; carrier gas, helium, adjusted to a linear velocity of 30 cm/s; split ratio, 1:40; ionization energy, 70 eV; scan range, 40&#x02013;300 u; scan time, 1 s. The identity of the components was assigned by comparison of their retention indices, relative to C<sub>9</sub>-C<sub>17</sub>
<italic>n</italic>-alkane indices, and GC-MS spectra from a laboratory-made library based upon the analyses of reference oils, laboratory-synthesized components, and commercial available standards.</p></sec></sec><sec id="sec2dot2-medicines-05-00061"><title>2.2. Determination of Antioxidant Activity</title><p>Antioxidant activity was determined with 2,2&#x02032;-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS<sup>+&#x02022;</sup>) free radical scavenging activity and oxygen radical absorbance capacity (ORAC) methods. For the ABTS method, the preformed radical monocation of ABTS<sup>+&#x02022;</sup> was generated by dissolving ABTS in water (7 mM), adding potassium persulfate (2.45 mM, final concentration), and allowing the mixture to stand overnight in the dark at room temperature. Before the assay, the ABTS<sup>+&#x02022;</sup> solution was diluted with ethanol to obtain a solution with absorbance of 0.70 at 734 nm [<xref rid="B20-medicines-05-00061" ref-type="bibr">20</xref>]. For the assay, 10 &#x003bc;L of sample were added to 1000 &#x003bc;L of ABTS<sup>+&#x02022;</sup> solution and left to stand for 6 min, after which the absorbance was read spectrophotometrically at 734 nm. For the control, the volume of sample was replaced by ethanol. The antioxidant activity of each sample was calculated as scavenging effect % (IA%, Inhibitory Activity Percentage) = [(A<sub>0</sub> &#x02212; A<sub>1</sub>)/A<sub>0</sub>] &#x000d7; 100, where A<sub>0</sub> is the absorbance of the control, and A<sub>1</sub> is the absorbance of the sample. The same procedure was repeated using diverse concentrations of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) [<xref rid="B21-medicines-05-00061" ref-type="bibr">21</xref>]. The values obtained with the samples were compared with the curve for several Trolox concentrations and the final results given as &#x003bc;mol Trolox equivalent (TE)/g EOs. Tests were carried out in triplicate.</p><p>For the ORAC assay, fluorescein (FL) was used as fluorescent probe [<xref rid="B22-medicines-05-00061" ref-type="bibr">22</xref>]. Briefly, in each well 150 &#x000b5;L of fluorescein working solution and 25 &#x000b5;L of the previously diluted sample, blank (75 mM phosphate buffer), or standard (Trolox) were added. The plate was covered with a lid and incubated in the preheated (37 &#x000b0;C) BioTek Synergy<sup>TM</sup> 4 Hybrid Microplate Reader (BioTek, Swindon, UK), country) for 10 min after shaking for 3 min. Then 2,2&#x02032;-Azobis-2-methyl-propanimidamide dihydrochloride (AAPH) was added to each well of the plate, except for the control and blank wells. The final volume of the assay was 200 &#x000b5;L. The fluorescence was read every minute for 90 min at 485 nm excitation and 527 nm emissions. ORAC values were calculated according to [<xref rid="B23-medicines-05-00061" ref-type="bibr">23</xref>]. Briefly, the net area under the curve (AUC) of the standard (Trolox) and samples was calculated. The standard curve was obtained by plotting Trolox concentrations against the average net AUC of the measurements for each concentration. Final ORAC values were calculated using the regression equation between Trolox concentration and the net AUC and were expressed as &#x000b5;mol TE/g EO [<xref rid="B24-medicines-05-00061" ref-type="bibr">24</xref>]. Tests were carried out in triplicate.</p></sec><sec id="sec2dot3-medicines-05-00061"><title>2.3. Determination of Antibacterial Activity</title><p>Antibacterial activity was determined against two strains of <italic>Streptococcus pneumoniae</italic> D39 and TIGR4, and <italic>Haemophilus influenza</italic> DSM 9999. Bacterial strains were kept at &#x02212;70 &#x000b0;C in brain heart infusion (BHI) (Oxoid) supplemented with glycerol (final concentration 25%, <italic>v</italic>/<italic>v</italic>) until use. The cultures were recovered from freezing by growth in brain heart infusion supplemented with 5% (<italic>v</italic>/<italic>v</italic>) horse blood at 37 &#x000b0;C in microaerophilic conditions. Prior to the assay bacterial cultures were grown in Columbia agar (Oxoid) plates supplemented with 5% (<italic>v</italic>/<italic>v</italic>) horse blood at 37 &#x000b0;C in microaerophilic conditions for 24 h. From this plate a suspension with a turbidity value corresponding to 0.5 in the McFarland scale was prepared. From this suspension 0.1 mL was transferred to a new Columbia agar plate supplemented with 5% (<italic>v</italic>/<italic>v</italic>) horse blood. Sterile filter paper discs of 6 mm (Oxoid) were distributed on the agar surface and 3 &#x003bc;L of each essential oil was dispensed in the paper discs. Tea tree essential oil with 38% terpinen-4-ol (Optima Healthcare Ltd., Bradford, UK) was included as reference. Sterile <italic>n</italic>-propanol (essential oil solvent) and the antibiotic chloramphenicol (30 &#x003bc;g/disk) were used as control. Inhibition zones were evaluated after 24 h at 37 &#x000b0;C in microaerophilic conditions. The assays were done in triplicate.</p><p>The minimum inhibitory concentration (MIC) for the tested EOs was determined using a microdilution method [<xref rid="B6-medicines-05-00061" ref-type="bibr">6</xref>,<xref rid="B25-medicines-05-00061" ref-type="bibr">25</xref>]. Concentrations ranging from 0 to 0.4 mg/mL with increments of 0.05 mg/mL were tested. Three replicates for each bacterium were used. The recovery of the viability of each bacterium was evaluated, and the minimum concentration at which no viability was observed was considered as the minimum bactericidal concentration (MBC).</p></sec><sec id="sec2dot4-medicines-05-00061"><title>2.4. Determination of Antiproliferative Activity</title><p>Human leukaemic cell line THP-1 cells were cultured in Dulbecco&#x02019;s Modified Eagle Medium (DMEM) supplemented with 10% (<italic>v</italic>/<italic>v</italic>) foetal bovine serum, 1% (<italic>v</italic>/<italic>v</italic>) nonessential amino acids, 100U/mL penicillin, and 100 &#x003bc;g/mL streptomycin, according to [<xref rid="B24-medicines-05-00061" ref-type="bibr">24</xref>]. They were incubated at 37 &#x000b0;C in a humidified 5% CO<sub>2</sub> atmosphere.</p><p>The growth inhibitory effect of EOs was measured using the 3-(4,5-dimethylthiazol-2-yl) 2,5-diphenyltetrazolium bromide (MTT) assay [<xref rid="B26-medicines-05-00061" ref-type="bibr">26</xref>]. THP-1 cells were seeded in 96-well plate at 5 &#x000d7; 10<sup>3</sup> cells/well and submitted to different EO concentrations (10&#x02013;500 &#x003bc;g/mL). All samples were dissolved in dimethyl-sulfoxide (DMSO). The solvent concentration in the incubation medium never exceeded 0.5%. Control cultures had the equivalent concentration of DMSO. After treatment, cells were incubated (1 h) in the usual culture conditions after addition of the same volume of medium containing MTT (2 mg/mL). After this period, 150 &#x003bc;L HCl (0.1 M) in isopropanol was added to dissolve the blue formazan crystals formed owing to the reduction of MTT. Absorbance at 570 nm using a background reference wavelength of 630 nm was measured. Antiproliferative activity was expressed as the mean absorbance values for the negative control (DMSO-treated cells) standardized as 100% absorbance (i.e., no growth inhibition) and results were expressed as absorbance (% of control) versus essential oil concentration [<xref rid="B24-medicines-05-00061" ref-type="bibr">24</xref>].</p></sec><sec id="sec2dot5-medicines-05-00061"><title>2.5. Statistical Analysis</title><p>Data were analysed by one-way analysis of variance (ANOVA) using IBM SPSS Statistics version 23 (IBM, Armonk, NY, USA). Tukey&#x02019;s test was used to determine the difference at 5% significance level.</p></sec></sec><sec id="sec3-medicines-05-00061"><title>3. Results and Discussion</title><sec id="sec3dot1-medicines-05-00061"><title>3.1. Antioxidant Activity</title><p>The antioxidant activity of the EO was determined with an electron reaction-based method (the ABTS+ method) and a hydrogen reaction-based method (the ORAC method). With the TEAC method, Cc EO showed significantly higher antioxidant activity (5.08 &#x000b5;mol TE/g EO) than <italic>Eucalyptus</italic> EOs (<xref rid="medicines-05-00061-t002" ref-type="table">Table 2</xref>). The lowest antioxidant activity was observed with Eg, Ep, Er and Es EOs, without significant differences among them. The activities ranged from 0.10 in Es to 0.30 &#x003bc;mol TE/g in Eg EO. Cc EO showed the highest scavenging peroxyl radical activity (148.55 &#x000b5;mol TE/g EO) along with Ev EO (135.80 &#x000b5;mol TE/g EO) (<xref rid="medicines-05-00061-t002" ref-type="table">Table 2</xref>). Eu EO (37.14 &#x000b5;mol TE/g EO) showed the lowest peroxyl radical scavenging activity.</p><p>Results for the essential oils of Cc and Es are in agreement with those previously reported by Luis et al. [<xref rid="B28-medicines-05-00061" ref-type="bibr">28</xref>] for these species. In Luis et al. [<xref rid="B28-medicines-05-00061" ref-type="bibr">28</xref>] study, citronellal (78%) was the main component for <italic>Corymbia citriodora</italic> EO, and 1,8-cineole (82%) dominated in <italic>Eucalyptus smithii</italic> EO.</p><p>Citronellal shows moderate antioxidant activity due to its limited capacity to scavenge free radicals [<xref rid="B29-medicines-05-00061" ref-type="bibr">29</xref>]. The antioxidant activity of citronellal may be related to one unpaired electron from the molecule allylic hydrogen of both CH<sub>3</sub> or CH<sub>2</sub> (<xref ref-type="fig" rid="medicines-05-00061-f001">Figure 1</xref>) that by resonance stabilize the radical formed after the reaction. Nevertheless, Wojtunik et al. [<xref rid="B30-medicines-05-00061" ref-type="bibr">30</xref>] considered that only the presence of conjugation of &#x003c0; bonds would allow a resonance-stabilized structure. However, essential oils are complex mixtures and the antioxidant activity cannot be assigned to only one compound. The different constituents of EOs may act synergistically or antagonistically, leading to an overall activity that results from the interaction among several compounds. Ciesla et al. [<xref rid="B29-medicines-05-00061" ref-type="bibr">29</xref>] studied the capacity of binary mixtures of some common EO terpenoids, for scavenging DPPH free radicals. They reported an antagonistic effect between citronellal and 1,8-cineole, both present in Cc EO. Nonetheless, the interaction of citronellal with other constituents could trigger a synergistic effect, responsible for the high level of activity observed in Cc EO. Antagonism was also observed by Ciesla et al. [<xref rid="B29-medicines-05-00061" ref-type="bibr">29</xref>] for the binary mixture of 1,8-cineole and <italic>p</italic>-cymene. These constituents were the major Er EO compounds (<xref rid="medicines-05-00061-t001" ref-type="table">Table 1</xref>). Eg, Ep, Er, and Es EOs, which showed the lowest free radical scavenger activities, had 1,8-cineole, &#x003b1;-pinene, and <italic>p</italic>-cymene as major constituents. These monoterpenes were previously reported as poor scavengers of DPPH free radicals [<xref rid="B31-medicines-05-00061" ref-type="bibr">31</xref>]. &#x003b3;-Terpinene, one of the main constituents of Ev EO, is considered a good free radical scavenger [<xref rid="B29-medicines-05-00061" ref-type="bibr">29</xref>,<xref rid="B32-medicines-05-00061" ref-type="bibr">32</xref>], possibly due to the delocalization of the unpaired electron along the molecule, owing to the two allylic hydrogens that can stabilize the resonance-structures (<xref ref-type="fig" rid="medicines-05-00061-f001">Figure 1</xref>). Moreover, the binary mixture of &#x003b3;-terpinene and 1,8-cineole (another major constituent of Ev EO) did not produce any significant effects. Despite the presence of an allylic hydrogen in <italic>p</italic>-cymene in conjugation with an aromatic ring, its abstraction from the molecule can be difficult due to steric hindrances, because hydrogen is hidden by the two CH<sub>3</sub> groups as well as by the aromatic ring (<xref ref-type="fig" rid="medicines-05-00061-f001">Figure 1</xref>).</p></sec><sec id="sec3dot2-medicines-05-00061"><title>3.2. Antibacterial Activity</title><p>Essential oils of thyme, tea tree, peppermint, anise, fennel, and eucalyptus may be used for the treatment of simple respiratory tract diseases [<xref rid="B4-medicines-05-00061" ref-type="bibr">4</xref>]. <italic>Eucalyptus</italic> EOs have been used in the treatment of bronchitis, cold, cough, and in the symptomatic relief of catarrh of the upper respiratory tract [<xref rid="B4-medicines-05-00061" ref-type="bibr">4</xref>]. Tea tree EO has been used for treating some respiratory infections, such as bronchitis, cold, and influenza [<xref rid="B4-medicines-05-00061" ref-type="bibr">4</xref>].</p><p><italic>S. pneumoniae, H. influenzae,</italic> and <italic>Staphylococcus aureus</italic> have been associated with community-acquired pneumonia, along with the less common <italic>Pseudomonas aeruginosa</italic>, <italic>Pneumocystis jirovecii</italic>, <italic>Moraxella catarrhalis</italic>, and other Gram-negative bacteria [<xref rid="B33-medicines-05-00061" ref-type="bibr">33</xref>].</p><p>In the present work the capacity for inhibiting the growth of two strains of <italic>S. pneumoniae</italic> (D39 and TIGR4) and <italic>H. influenzae</italic> (DSM 9999) by Cc, Ed, Eg, Es and Ev EOs was evaluated and compared with that of tea tree EO and the antibiotic chloramphenicol (<xref rid="medicines-05-00061-t003" ref-type="table">Table 3</xref>).</p><p>All essential oils showed poor antibacterial activity in comparison with the antibiotic chloramphenicol, however differences could be observed among the EOs and bacterial strains (<xref rid="medicines-05-00061-t003" ref-type="table">Table 3</xref>). For example, all EOs were less effective against <italic>S. pneumoniae</italic> TIGR4 in comparison with <italic>S. pneumoniae</italic> D39. For <italic>S. pneumoniae</italic> TIGR 4, tea tree EO showed better activity than Myrtaceae EOs, and the strain was even resistant to Ed EO. For <italic>H. influenzae</italic>, no significant differences (<italic>p</italic> &#x0003e; 0.05) were observed between the antibacterial activity-assayed Myrtaceae EOs (<xref rid="medicines-05-00061-t003" ref-type="table">Table 3</xref>).</p><p>The MIC and MBC values were determined for Es, Eg, and tea tree EOs (<xref rid="medicines-05-00061-t004" ref-type="table">Table 4</xref>). The lowest MIC and MBC values were observed for Eg EO against <italic>S. pneumoniae</italic> TIGR 4, with values of 0.015 and 0.05 mg/mL, respectively. Both <italic>S. pneumoniae</italic> strains showed a similar MIC and MBC for the tea tree EO, namely 0.025 and 0.1 mg/mL, respectively. However, for the Es EO <italic>S. pneumoniae</italic> D39 showed a similar MIC value to <italic>S. pneumoniae</italic> TIGR 4, but the MBC value was the double of that of <italic>S. pneumoniae</italic> TIGR 4, showing an MBC of 0.3 mg/mL in contrast to TIGR 4 that showed an MBC of 0.15 mg/mL (<xref rid="medicines-05-00061-t004" ref-type="table">Table 4</xref>). Such differences may be associated with serotype differences between the strains. Moreover, Eg EO, that in the diffusion agar test showed a very weak activity against <italic>S. pneumoniae</italic> TIGR 4, displayed an efficient activity in the microdilution assay, even in comparison with tea tree EO. These differences may be related to its low diffusion ability. Intriguing was the resistant behaviour of <italic>H. influenza</italic> that was able to growth at the highest EO concentration tested (0.4 mg/mL). Eg EO showed a better activity against <italic>S. pneumoniae</italic>, that can be related with its richness in 1,8-cineole and &#x003b1;-pinene. In addition, 1,8-cineole prevents the growth of other microorganisms, but when in association with other terpenes in an essential oil, such as camphene, &#x003b1;-pinene, globulol and limonene, it was more efficient against <italic>S. aureus</italic>, methicillin-resistant <italic>S. aureus</italic> (MRSA), <italic>Escherichia coli</italic> and <italic>Candida albicans</italic>, and also biofilms of MRSA and <italic>P. aeruginosa</italic> [<xref rid="B34-medicines-05-00061" ref-type="bibr">34</xref>].</p></sec><sec id="sec3dot3-medicines-05-00061"><title>3.3. Antiproliferative Activity</title><p>The antiproliferative activities of <italic>Corymbia</italic> and <italic>Eucalyptus</italic> species EOs were studied with the THP-1 cell line (human acute monocytic leukaemia) using the MTT assay. Cells were incubated to increasing amounts of EOs for 24 h and 96 h (<xref ref-type="fig" rid="medicines-05-00061-f002">Figure 2</xref> and <xref ref-type="fig" rid="medicines-05-00061-f003">Figure 3</xref>).</p><p>EOs decreased viability of THP-1 cells in a dose-dependent manner. After one day, a great difference was observed between the antiproliferative activity of Eg and Es EOs and the other EOs, particularly at 50 &#x003bc;g/mL. Hence, Eg and Es EOs possessed the lowest antiproliferative activities. After 96 h incubation of THP1 cells with EOs, the differences were more evident for lower concentrations (10 and 25 &#x003bc;g/mL). At 25 &#x003bc;g/mL, it was possible to distinguish two EOs (Er and Ev) with significantly higher antiproliferative activity than the remaining EOs. At 50 &#x003bc;g/mL, these differences disappeared, because almost all EOs showed survival percentages &#x0003c;20%. The exceptions were Eg and Es EOs, that showed survival percentages above &#x0003e;70%, at 50 &#x003bc;g/mL. The main constituents of Eg EO were 1,8-cineole (64%) and &#x003b1;-pinene (20%), and in Es EO, 1,8-cineole represented 80% of the total EO (<xref rid="medicines-05-00061-t001" ref-type="table">Table 1</xref>). The major components of the Er and Ev EOs also included 1,8-cineole (48 and 46%, respectively), and other components such as <italic>p</italic>-cymene (13%) for Er and &#x003b1;-pinene (20%), and &#x003b3;-terpinene (12%) for Ev EOs (<xref rid="medicines-05-00061-t001" ref-type="table">Table 1</xref>). The results suggested that 1,8-cineole has low antiproliferative activity on the THP-1 leukaemia cell line, although in the presence of <italic>p</italic>-cymene or &#x003b3;-terpinene, the antiproliferative activity increased.</p><p>The weak antiproliferative activity of 1,8-cineole, <italic>p</italic>-cymene, &#x003b1;-pinene has been reported [<xref rid="B35-medicines-05-00061" ref-type="bibr">35</xref>], despite these monoterpenes having not been assayed together. Results may suggest a potential synergistic effect between the following pairs: 1,8-cineole and <italic>p</italic>-cymene, and 1,8-cineole with &#x003b3;-terpinene.</p></sec></sec><sec id="sec4-medicines-05-00061"><title>4. Conclusions</title><p>The highest scavenging of ABTS+ and peroxyl free radicals was observed in Cc and Ev EOs, and the lowest was detected in Eu EO. All essential oils were less effective against <italic>S. pneumoniae</italic> TIGR4 than against the D39 strain. MIC and MBC values showed that Eg EO is promising for the treatment of <italic>S. pneumoniae</italic> infections. EOs displayed low diffusion capacity and the antibacterial activity screening through microdilution test would be more appropriate. <italic>H. influenzae</italic> was the respiratory pathogen that showed the highest resistance to all EOs including that of tea tree. Eg and Es EOs showed the lowest antiproliferative activities on THP-1 cells. After 96 h incubation, the Er and Ev EOs showed the highest antiproliferative activity against THP-1 cells. Although further assays are required, the results suggest that the antiproliferative activity is challenged by the combination of 1,8-cineole with <italic>p</italic>-cymene or with &#x003b3;-terpinene. Despite their specific bioactivities, none of the assayed EOs showed simultaneously good antibacterial, antioxidant, and antiproliferative capacity.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge the Instituto da Conserva&#x000e7;&#x000e3;o da Natureza e das Florestas (ICNF) and particularly Eng Jo&#x000e3;o Sanches (Mata Experimental do Escaroupim (MEE)) from the Centro Nacional de Sementes Florestais (CENASEF) for kindly allowing the sampling of all studied species from the MEE.</p></ack><app-group><app id="app1-medicines-05-00061"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="http://www.mdpi.com/2305-6320/5/3/61/s1">http://www.mdpi.com/2305-6320/5/3/61/s1</uri>, Table S1: Percentage composition of the essential oil isolated from <italic>Eucalyptus delegatensis</italic> subsp. <italic>tasmaniensis</italic> Boland, previously included in the study of Sena et al. [<xref rid="B27-medicines-05-00061" ref-type="bibr">27</xref>] under the former name of <italic>E. gigantea</italic>.</p><supplementary-material content-type="local-data" id="medicines-05-00061-s001"><media xlink:href="medicines-05-00061-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>M.G.M., J.V. and A.C.F. conceived and designed the experiments; A.C.F. contributed to the chemical composition analysis of samples; C.G. and M.D.A. contributed to the antioxidant activity evaluation; S.L. carried out the antibacterial activities at CBMR/UAlg under the direction of M.L.F.; M.G.M., C.M. and I.C.-G. contributed to the work on antiproliferative activity. M.G.M., M.L.F., J.V. and A.C.F. contributed to the data handling. All authors have also contributed in writing the paper.</p></notes><notes><title>Funding</title><p>This study was partially funded by CESAM (UID/AMB/50017-POCI-01-0145-FEDER-007638), to FCT/MCTES through national funds (PIDDAC), and co-funding by the FEDER within the PT2020 Partnership Agreement and Compete 2020, and by the Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia (FCT), under the projects UID/BIA/04325/2013&#x02014;MEDTBIO, and UID/BIM/04773/2013 CBMR.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-medicines-05-00061"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulu</surname><given-names>W.</given-names></name><name><surname>Yizengaw</surname><given-names>E.</given-names></name><name><surname>Alemu</surname><given-names>M.</given-names></name><name><surname>Mekonnen</surname><given-names>D.</given-names></name><name><surname>Hailu</surname><given-names>D.</given-names></name><name><surname>Ketemaw</surname><given-names>K.</given-names></name><name><surname>Abera</surname><given-names>B.</given-names></name><name><surname>Kibret</surname><given-names>M.</given-names></name></person-group><article-title>Pharyngeal colonization and drug resistance profiles of <italic>Morraxella catarrhalis</italic>, <italic>Streptococcus pneumoniae</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Haemophilus influenzae</italic> among HIV infected children attending ART clinic of felegehiwot referral hospital, Ethiopia</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0196722</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0196722</pub-id><?supplied-pmid 29746496?><pub-id pub-id-type="pmid">29746496</pub-id></element-citation></ref><ref id="B2-medicines-05-00061"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;rtqvist</surname><given-names>A.</given-names></name><name><surname>Hedlund</surname><given-names>J.</given-names></name><name><surname>Kalin</surname><given-names>M.</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic>: Epidemology, risk factors, and clinical features</article-title><source>Semin. Respir. Crit. Care Med.</source><year>2005</year><volume>26</volume><fpage>563</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1055/s-2005-925523</pub-id><?supplied-pmid 16388428?><pub-id pub-id-type="pmid">16388428</pub-id></element-citation></ref><ref id="B3-medicines-05-00061"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochot</surname><given-names>A.</given-names></name><name><surname>Guilbot</surname><given-names>A.</given-names></name><name><surname>Haddioui</surname><given-names>L.</given-names></name><name><surname>Roques</surname><given-names>C.</given-names></name></person-group><article-title>Antibacterial, antifungal, and antiviral effects of three essential oil blends</article-title><source>MicrobiologyOpen</source><year>2017</year><volume>6</volume><fpage>e459</fpage><pub-id pub-id-type="doi">10.1002/mbo3.459</pub-id><?supplied-pmid 28296357?><pub-id pub-id-type="pmid">28296357</pub-id></element-citation></ref><ref id="B4-medicines-05-00061"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horv&#x000e1;th</surname><given-names>G.</given-names></name><name><surname>&#x000c1;cs</surname><given-names>K.</given-names></name></person-group><article-title>Essential oils in the treatment of respiratory tract diseases highlighting their role in bacterial infections and their anti-inflammatory action: A review</article-title><source>Flavour Fragr. J.</source><year>2015</year><volume>30</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1002/ffj.3252</pub-id></element-citation></ref><ref id="B5-medicines-05-00061"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouhan</surname><given-names>S.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Guleria</surname><given-names>S.</given-names></name></person-group><article-title>Antimicrobial activity of some essential oils&#x02014;Present status and future perspectives</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>58</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4030058</pub-id><?supplied-pmid 28930272?><pub-id pub-id-type="pmid">28930272</pub-id></element-citation></ref><ref id="B6-medicines-05-00061"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apol&#x000f3;nio</surname><given-names>J.</given-names></name><name><surname>Faleiro</surname><given-names>M.L.</given-names></name><name><surname>Miguel</surname><given-names>M.G.</given-names></name><name><surname>Neto</surname><given-names>L.</given-names></name></person-group><article-title>No induction of antimicrobial resistance in <italic>Staphylococcus aureus</italic> and <italic>Listeria monocytogenes</italic> during continuous exposure to eugenol and citral</article-title><source>FEMS Microbiol. Lett.</source><year>2014</year><volume>354</volume><fpage>92</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1111/1574-6968.12440</pub-id><?supplied-pmid 24716611?><pub-id pub-id-type="pmid">24716611</pub-id></element-citation></ref><ref id="B7-medicines-05-00061"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ung</surname><given-names>L.</given-names></name><name><surname>Pattamatta</surname><given-names>U.</given-names></name><name><surname>Carnt</surname><given-names>N.</given-names></name><name><surname>Wilkinson-Berka</surname><given-names>J.L.</given-names></name><name><surname>Liew</surname><given-names>G.</given-names></name></person-group><article-title>Oxidative stress and reactive oxygen species: A review of their role in ocular disease</article-title><source>Clin. Sci.</source><year>2017</year><volume>131</volume><fpage>2865</fpage><lpage>2883</lpage><pub-id pub-id-type="doi">10.1042/CS20171246</pub-id><?supplied-pmid 29203723?><pub-id pub-id-type="pmid">29203723</pub-id></element-citation></ref><ref id="B8-medicines-05-00061"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Gal</surname><given-names>K.</given-names></name><name><surname>Ibrahim</surname><given-names>M.X.</given-names></name><name><surname>wiel</surname><given-names>C.</given-names></name><name><surname>Sayin</surname><given-names>V.I.</given-names></name><name><surname>Akula</surname><given-names>M.K.</given-names></name><name><surname>Karlsson</surname><given-names>C.</given-names></name><name><surname>Dalin</surname><given-names>M.G.</given-names></name><name><surname>Aky&#x000fc;rek</surname><given-names>L.M.</given-names></name><name><surname>Lindahl</surname><given-names>P.</given-names></name><name><surname>Nilsson</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Antioxidants can increase melanoma metastasis in mice</article-title><source>Sci. Transl. Med.</source><year>2015</year><volume>7</volume><fpage>308re8</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aad3740</pub-id><?supplied-pmid 26446958?><pub-id pub-id-type="pmid">26446958</pub-id></element-citation></ref><ref id="B9-medicines-05-00061"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blowman</surname><given-names>K.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>M.</given-names></name><name><surname>Lemos</surname><given-names>M.F.L.</given-names></name><name><surname>Cabral</surname><given-names>C.</given-names></name><name><surname>Pires</surname><given-names>I.M.</given-names></name></person-group><article-title>Anticancer properties of essential oils and other natural products</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2018</year><volume>3149362</volume><pub-id pub-id-type="doi">10.1155/2018/3149362</pub-id><?supplied-pmid 29765461?><pub-id pub-id-type="pmid">29765461</pub-id></element-citation></ref><ref id="B10-medicines-05-00061"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>K.D.</given-names></name><name><surname>Johnson</surname><given-names>L.A.S.</given-names></name></person-group><article-title>Systematic studies in the eucalypts. 7. A revision of the bloodwoods, genus <italic>Corymbia</italic> (Myrtaceae)</article-title><source>Telopea</source><year>1995</year><volume>6</volume><fpage>185</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.7751/telopea19953017</pub-id></element-citation></ref><ref id="B11-medicines-05-00061"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brophy</surname><given-names>J.J.</given-names></name><name><surname>Forster</surname><given-names>P.I.</given-names></name><name><surname>Goldsack</surname><given-names>R.J.</given-names></name><name><surname>Hibbert</surname><given-names>D.B.</given-names></name></person-group><article-title>The essential oils of the yellow bloodwood eucalypts (<italic>Corymbia</italic>, section <italic>Ochraria</italic>, Myrtaceae)</article-title><source>Biochem. Syst. Ecol.</source><year>1998</year><volume>26</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1016/S0305-1978(97)00105-1</pub-id></element-citation></ref><ref id="B12-medicines-05-00061"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>L.C.A.</given-names></name><name><surname>Filomeno</surname><given-names>C.A.</given-names></name><name><surname>Teixeira</surname><given-names>R.R.</given-names></name></person-group><article-title>Chemical variability and biological activities of <italic>Eucalyptus</italic> spp. essential oils</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1671</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21121671</pub-id><?supplied-pmid 27941612?><pub-id pub-id-type="pmid">27941612</pub-id></element-citation></ref><ref id="B13-medicines-05-00061"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilles</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>An</surname><given-names>M.</given-names></name><name><surname>Agboola</surname><given-names>S.</given-names></name></person-group><article-title>Chemical composition and antimicrobial properties of essential oils of three Australian <italic>Eucalyptus</italic> species</article-title><source>Food Chem.</source><year>2010</year><volume>119</volume><fpage>731</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2009.07.021</pub-id></element-citation></ref><ref id="B14-medicines-05-00061"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>S.M.</given-names></name><name><surname>Abe</surname><given-names>S.Y.</given-names></name><name><surname>Murakami</surname><given-names>F.S.</given-names></name><name><surname>Frensch</surname><given-names>G.</given-names></name><name><surname>Marques</surname><given-names>F.A.</given-names></name><name><surname>Nakashima</surname><given-names>T.</given-names></name></person-group><article-title>Essential oils from different plant parts of <italic>Eucalyptus cinerea</italic> F. Muell. Ex Benth. (Myrtaceae) as a source of 1,8-cineole and their bioactivities</article-title><source>Pharmaceuticals</source><year>2011</year><volume>4</volume><fpage>1535</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.3390/ph4121535</pub-id><?supplied-pmid 26791641?><pub-id pub-id-type="pmid">26791641</pub-id></element-citation></ref><ref id="B15-medicines-05-00061"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhakad</surname><given-names>A.</given-names></name><name><surname>Pandey</surname><given-names>V.V.</given-names></name><name><surname>Beg</surname><given-names>S.</given-names></name><name><surname>Rawat</surname><given-names>J.M.</given-names></name><name><surname>Singh</surname><given-names>A.</given-names></name></person-group><article-title>Biological, medicinal and toxicological significance of <italic>Eucalyptus</italic> leaf essential oil: A review</article-title><source>J. Sci. Food Agric.</source><year>2018</year><volume>98</volume><fpage>833</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1002/jsfa.8600</pub-id><?supplied-pmid 28758221?><pub-id pub-id-type="pmid">28758221</pub-id></element-citation></ref><ref id="B16-medicines-05-00061"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>M.S.</given-names></name><name><surname>Barbosa</surname><given-names>P.</given-names></name><name><surname>Bennett</surname><given-names>R.N.</given-names></name><name><surname>Mota</surname><given-names>M.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name></person-group><article-title>Bioactivity against <italic>Bursaphelenchus xylophilus</italic>: Nematotoxics from essential oils, essential oils fractions and decoction waters</article-title><source>Phytochemistry</source><year>2013</year><volume>94</volume><fpage>220</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.06.005</pub-id><?supplied-pmid 23829930?><pub-id pub-id-type="pmid">23829930</pub-id></element-citation></ref><ref id="B17-medicines-05-00061"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>P.</given-names></name><name><surname>Faria</surname><given-names>J.M.S.</given-names></name><name><surname>Mendes</surname><given-names>M.D.</given-names></name><name><surname>Dias</surname><given-names>L.S.</given-names></name><name><surname>Tinoco</surname><given-names>M.T.</given-names></name><name><surname>Barroso</surname><given-names>J.G.</given-names></name><name><surname>Pedro</surname><given-names>L.G.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name><name><surname>Mota</surname><given-names>M.</given-names></name></person-group><article-title>Bioassays against Pinewood nematode: Assessment of a suitable dilution agent and screening for bioactive essential oils</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>12312</fpage><lpage>12329</lpage><pub-id pub-id-type="doi">10.3390/molecules171012312</pub-id><?supplied-pmid 23085666?><pub-id pub-id-type="pmid">23085666</pub-id></element-citation></ref><ref id="B18-medicines-05-00061"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>J.M.S.</given-names></name><name><surname>Sanches</surname><given-names>J.</given-names></name><name><surname>Lima</surname><given-names>A.S.</given-names></name><name><surname>Mendes</surname><given-names>M.D.</given-names></name><name><surname>Leiria</surname><given-names>R.</given-names></name><name><surname>Geraldes</surname><given-names>D.A.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name><name><surname>Trindade</surname><given-names>H.</given-names></name><name><surname>Pedro</surname><given-names>L.G.</given-names></name><name><surname>Barroso</surname><given-names>J.G.</given-names></name></person-group><article-title><italic>Eucalyptus</italic> from Mata Experimental do Escaroupim (Portugal): Evaluation of the essential oil composition from sixteen species</article-title><source>Acta Hortic.</source><year>2011</year><volume>925</volume><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.17660/ActaHortic.2011.925.7</pub-id></element-citation></ref><ref id="B19-medicines-05-00061"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Council of Europe (COE)</collab><collab>European Directorate for the Quality of Medicines</collab></person-group><source>European Pharmacopoeia</source><edition>6th ed.</edition><publisher-name>Council of Europe (COE)</publisher-name><publisher-loc>Strasbourg, France</publisher-loc><year>2007</year></element-citation></ref><ref id="B20-medicines-05-00061"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Re</surname><given-names>R.</given-names></name><name><surname>Pellegrini</surname><given-names>N.</given-names></name><name><surname>Proteggente</surname><given-names>A.</given-names></name><name><surname>Pannala</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name><name><surname>Rice-Evans</surname><given-names>C.</given-names></name></person-group><article-title>Antioxidant activity applying an improved ABTS radical cation decolorization assay</article-title><source>Free Rad. Biol. Med.</source><year>1999</year><volume>26</volume><fpage>1231</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(98)00315-3</pub-id><pub-id pub-id-type="pmid">10381194</pub-id></element-citation></ref><ref id="B21-medicines-05-00061"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname><given-names>M.D.C.</given-names></name><name><surname>Dandlen</surname><given-names>S.</given-names></name><name><surname>Cavaco</surname><given-names>A.M.</given-names></name><name><surname>Miguel</surname><given-names>G.</given-names></name></person-group><article-title>Effects of postharvest application of 1-MCP and postcutting dip treatment on the quality and nutritional properties of fresh-cut kiwifruit</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>6173</fpage><lpage>6181</lpage><pub-id pub-id-type="doi">10.1021/jf904540m</pub-id><?supplied-pmid 20411941?><pub-id pub-id-type="pmid">20411941</pub-id></element-citation></ref><ref id="B22-medicines-05-00061"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>B.</given-names></name><name><surname>Hampsch-Woodill</surname><given-names>M.</given-names></name><name><surname>Prior</surname><given-names>R.L.</given-names></name></person-group><article-title>Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe</article-title><source>J. Agric. Food Chem.</source><year>2001</year><volume>49</volume><fpage>4619</fpage><lpage>4626</lpage><pub-id pub-id-type="doi">10.1021/jf010586o</pub-id><?supplied-pmid 11599998?><pub-id pub-id-type="pmid">11599998</pub-id></element-citation></ref><ref id="B23-medicines-05-00061"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D.</given-names></name><name><surname>Ou</surname><given-names>B.</given-names></name><name><surname>Hampsch-Woodill</surname><given-names>M.</given-names></name><name><surname>Flanagan</surname><given-names>J.A.</given-names></name><name><surname>Prior</surname><given-names>R.L.</given-names></name></person-group><article-title>High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>4437</fpage><lpage>4444</lpage><pub-id pub-id-type="doi">10.1021/jf0201529</pub-id><?supplied-pmid 12137457?><pub-id pub-id-type="pmid">12137457</pub-id></element-citation></ref><ref id="B24-medicines-05-00061"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel</surname><given-names>M.G.</given-names></name><name><surname>Gago</surname><given-names>C.</given-names></name><name><surname>Antunes</surname><given-names>M.D.</given-names></name><name><surname>Meg&#x000ed;as</surname><given-names>C.</given-names></name><name><surname>Cort&#x000e9;s-Giraldo</surname><given-names>I.</given-names></name><name><surname>Vioque</surname><given-names>J.</given-names></name><name><surname>Lima</surname><given-names>A.S.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name></person-group><article-title>Antioxidant and antiproliferative activities of the essential oils from <italic>Thymbra capitata</italic> and <italic>Thymus</italic> species grown in Portugal</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2015</year><volume>2015</volume><fpage>851721</fpage><pub-id pub-id-type="doi">10.1155/2015/851721</pub-id><?supplied-pmid 26229547?><pub-id pub-id-type="pmid">26229547</pub-id></element-citation></ref><ref id="B25-medicines-05-00061"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faleiro</surname><given-names>L.</given-names></name><name><surname>Miguel</surname><given-names>G.</given-names></name><name><surname>Gomes</surname><given-names>S.</given-names></name><name><surname>Costa</surname><given-names>L.</given-names></name><name><surname>Ven&#x000e2;ncio</surname><given-names>F.</given-names></name><name><surname>Teixeira</surname><given-names>A.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name><name><surname>Barroso</surname><given-names>J.A.</given-names></name><name><surname>Pedro</surname><given-names>L.G.</given-names></name></person-group><article-title>Antibacterial and antioxidant activities of essential oils isolated from <italic>Thymbra capitata</italic> L. (Cav.) and <italic>Origanum vulgare</italic> L.</article-title><source>J. Agric. Food Chem.</source><year>2005</year><volume>53</volume><fpage>8162</fpage><lpage>8168</lpage><pub-id pub-id-type="doi">10.1021/jf0510079</pub-id><?supplied-pmid 16218659?><pub-id pub-id-type="pmid">16218659</pub-id></element-citation></ref><ref id="B26-medicines-05-00061"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T.</given-names></name></person-group><article-title>Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</article-title><source>J. Immunol. Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id><pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref><ref id="B27-medicines-05-00061"><label>27.</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Sena</surname><given-names>I.</given-names></name><name><surname>Faria</surname><given-names>J.M.S.</given-names></name><name><surname>Sanches</surname><given-names>J.</given-names></name><name><surname>Trindade</surname><given-names>H.</given-names></name><name><surname>Pedro</surname><given-names>L.G.</given-names></name><name><surname>Barroso</surname><given-names>J.G.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name></person-group><article-title>Essential oil composition from twenty-six <italic>Eucalyptus</italic> taxa from Mata Experimental do Escaroupim (Portugal)</article-title><source>Proceedings of the 43rd International Symposium on Essential Oils</source><conf-loc>Lisboa, Portugal</conf-loc><conf-date>5&#x02013;8 September 2012</conf-date><fpage>216</fpage></element-citation></ref><ref id="B28-medicines-05-00061"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luis</surname><given-names>A.</given-names></name><name><surname>Duarte</surname><given-names>A.P.</given-names></name><name><surname>Pereira</surname><given-names>L.</given-names></name><name><surname>Domingues</surname><given-names>F.</given-names></name></person-group><article-title>Chemical profiling and evaluation of antioxidant and anti-microbial properties of selected commercial essential oils: A comparative study</article-title><source>Medicines</source><year>2017</year><volume>4</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3390/medicines4020036</pub-id><?supplied-pmid 28930251?><pub-id pub-id-type="pmid">28930251</pub-id></element-citation></ref><ref id="B29-medicines-05-00061"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciesla</surname><given-names>L.M.</given-names></name><name><surname>Wojtunik-Kulesza</surname><given-names>K.A.</given-names></name><name><surname>Oniszczuk</surname><given-names>A.</given-names></name><name><surname>Waksmundzka-Hajnos</surname><given-names>M.</given-names></name></person-group><article-title>Antioxidant synergism and antagonism between selected monoterpenes using the 2,2-diphenyl-1-picrylhydrazyl method</article-title><source>Flavour Fragr. J.</source><year>2016</year><volume>31</volume><fpage>412</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1002/ffj.3330</pub-id></element-citation></ref><ref id="B30-medicines-05-00061"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojtunik</surname><given-names>K.A.</given-names></name><name><surname>Ciesla</surname><given-names>L.M.</given-names></name><name><surname>Waksmundzka-Hajnos</surname><given-names>M.</given-names></name></person-group><article-title>Model studies on the antioxidant activity of common terpenoid constituents of essential oils by means of the 2,2-diphenyl-1-picrylhydrazyl method</article-title><source>J. Agric. Food Chem.</source><year>2014</year><volume>62</volume><fpage>9088</fpage><lpage>9094</lpage><pub-id pub-id-type="doi">10.1021/jf502857s</pub-id><?supplied-pmid 25152006?><pub-id pub-id-type="pmid">25152006</pub-id></element-citation></ref><ref id="B31-medicines-05-00061"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aazza</surname><given-names>S.</given-names></name><name><surname>Lyoussi</surname><given-names>B.</given-names></name><name><surname>Miguel</surname><given-names>M.G.</given-names></name></person-group><article-title>Antioxidant and antiacetylcholinesterase activities of some commercial essential oils and their major compounds</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>7672</fpage><lpage>7690</lpage><pub-id pub-id-type="doi">10.3390/molecules16097672</pub-id><?supplied-pmid 21900869?><pub-id pub-id-type="pmid">21900869</pub-id></element-citation></ref><ref id="B32-medicines-05-00061"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G.-X.</given-names></name><name><surname>Liu</surname><given-names>Z.-Q.</given-names></name></person-group><article-title>Unusual antioxidant behavior of &#x003b1;- and &#x003b3;-terpinene in protecting methyl linoleate, DNA, and erythrocyte</article-title><source>J. Agric. Food Chem.</source><year>2009</year><volume>57</volume><fpage>3943</fpage><lpage>3948</lpage><pub-id pub-id-type="doi">10.1021/jf803358g</pub-id><?supplied-pmid 19326866?><pub-id pub-id-type="pmid">19326866</pub-id></element-citation></ref><ref id="B33-medicines-05-00061"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>G.-L.</given-names></name><name><surname>Seon</surname><given-names>S.-H.</given-names></name><name><surname>Rhee</surname><given-names>D.-H.</given-names></name></person-group><article-title>Pneumonia and <italic>Streptococcus pneumoniae</italic> vaccine</article-title><source>Arch. Pharm. Res.</source><year>2017</year><volume>40</volume><fpage>885</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1007/s12272-017-0933-y</pub-id><?supplied-pmid 28735461?><pub-id pub-id-type="pmid">28735461</pub-id></element-citation></ref><ref id="B34-medicines-05-00061"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendry</surname><given-names>E.R.</given-names></name><name><surname>Worthington</surname><given-names>T.</given-names></name><name><surname>Conway</surname><given-names>B.R.</given-names></name><name><surname>Lambert</surname><given-names>P.A.</given-names></name></person-group><article-title>Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures</article-title><source>J. Antimicrob. Chemother.</source><year>2009</year><volume>64</volume><fpage>1219</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1093/jac/dkp362</pub-id><?supplied-pmid 19837714?><pub-id pub-id-type="pmid">19837714</pub-id></element-citation></ref><ref id="B35-medicines-05-00061"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aazza</surname><given-names>S.</given-names></name><name><surname>Lyoussi</surname><given-names>B.</given-names></name><name><surname>Meg&#x000ed;as</surname><given-names>C.</given-names></name><name><surname>Cort&#x000e9;s-Giraldo</surname><given-names>I.</given-names></name><name><surname>Vioque</surname><given-names>J.</given-names></name><name><surname>Figueiredo</surname><given-names>A.C.</given-names></name><name><surname>Miguel</surname><given-names>M.G.</given-names></name></person-group><article-title>Anti-oxidant, anti-inflammatory and anti-proliferative activities of Moroccan commercial essential oils</article-title><source>Nat. Prod. Commun.</source><year>2014</year><volume>9</volume><fpage>587</fpage><lpage>594</lpage><?supplied-pmid 24868891?><pub-id pub-id-type="pmid">24868891</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="medicines-05-00061-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structure of citronellal, &#x003b3;-terpinene and <italic>p</italic>-cymene. Citronellal and &#x003b3;-terpinene representing the allylic hydrogens. The radical formed can be stabilized by resonance.</p></caption><graphic xlink:href="medicines-05-00061-g001"/></fig><fig id="medicines-05-00061-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Antiproliferative activity of the EOs on THP-1 cell line after 24 h of exposure. The mean absorbance values for the negative control (dimethyl-sulfoxide (DMSO)-treated cells) were standardized as 100% absorbance (i.e., no growth inhibition) and results were displayed as absorbance (% of control) versus essential oil concentration.</p></caption><graphic xlink:href="medicines-05-00061-g002"/></fig><fig id="medicines-05-00061-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Antiproliferative activity of EOs on THP-1 cell line after 96 h of exposure. The mean absorbance values for the negative control (DMSO-treated cells) were standardized as 100% absorbance (i.e., no growth inhibition) and results were displayed as absorbance (% of control) versus essential oil concentration.</p></caption><graphic xlink:href="medicines-05-00061-g003"/></fig><table-wrap id="medicines-05-00061-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-05-00061-t001_Table 1</object-id><label>Table 1</label><caption><p>Studied <italic>Corymbia</italic> and <italic>Eucalyptus</italic> species. Currently accepted scientific names for plant species, arranged in alphabetic order of the corresponding plant family, sampling year, plant part used for hydrodistillation, plant source, essential oil yield, and main essential oil components (&#x02265;10%).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family/Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SY</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PP</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CP</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Yield (%, <italic>v</italic>/<italic>w</italic>)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Components (&#x02265;10%) *</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myrtaceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Current accepted species name</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synonyms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Corymbia citriodora</italic> (Hook.) K.D.Hill &#x00026; L.A.S.Johnson <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Corymbia citriodora</italic> subsp. <italic>variegata</italic> (F.Muell.) A.R.Bean &#x00026; M.W.McDonald, <italic>Corymbia variegata</italic> (F.Muell.) K.D.Hill &#x00026; L.A.S.Johnson, <italic>Eucalyptus citriodora</italic> Hook., <italic>Eucalyptus maculata</italic> var. <italic>citriodora</italic> (Hook.) F.M.Bailey, <italic>Eucalyptus melissiodora</italic> Lindl., <italic>Eucalyptus variegata</italic> F.Muell.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cc</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">citronellal 36, isopulegol 13, citronellol 12, 1,8-cineole 11</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus dives</italic> Schauer <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus amygdalina</italic> var. <italic>latifolia</italic> H.Deane &#x00026; Maiden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">piperitone 40, &#x003b1;-phellandrene 19, <italic>p</italic>-cymene 19</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus globulus</italic> Labill. <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus gigantea</italic> Dehnh., <italic>Eucalyptus glauca</italic> A.Cunn. ex DC., <italic>Eucalyptus globulosus</italic> St.-Lag., <italic>Eucalyptus globulus</italic> subsp. <italic>globulus</italic>, <italic>Eucalyptus maidenii</italic> subsp. <italic>globulus</italic> (Labill.) J.B.Kirkp., <italic>Eucalyptus perfoliata</italic> Desf., <italic>Eucalyptus pulverulenta</italic> Link</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eg</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lisbon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8-Cineole 64, &#x003b1;-pinene 20</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus delegatensis</italic> subsp. <italic>tasmaniensis</italic> Boland <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus gigantea</italic> Hook.f., <italic>Eucalyptus risdonii</italic> var. <italic>elata</italic> Benth., <italic>Eucalyptus tasmanica</italic> Blakely</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Edt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limonene 36, <italic>p</italic>-cymene 11, 1,8-cineole 10</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus pauciflora</italic> Sieber ex Spreng <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus coriacea</italic> A.Cunn. ex Schauer, <italic>Eucalyptus coriacea</italic> var. <italic>alpina</italic> Benth, <italic>Eucalyptus pauciflora</italic> var. <italic>alpina</italic> Ewart, <italic>Eucalyptus pauciflora</italic> subsp. <italic>pauciflora</italic>, <italic>Eucalyptus phlebophylla</italic> F.Muell. ex Miq., <italic>Eucalyptus submultiplinervis</italic> Miq., <italic>Eucalyptus sylvicultrix</italic> F.Muell. ex Benth.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ep</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-pinene 82</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus radiata</italic> A.Cunn. ex DC. <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus amygdalina</italic> var. <italic>radiata</italic> (A.Cunn. ex DC.) Benth., <italic>Eucalyptus australiana</italic> R.T.Baker &#x00026; H.G.Sm., <italic>Eucalyptus australiana</italic> var. <italic>latifolia</italic> R.T.Baker &#x00026; H.G.Sm., <italic>Eucalyptus phellandra</italic> R.T.Baker &#x00026; H.G.Sm., <italic>Eucalyptus radiata</italic> var. <italic>australiana</italic> (R.T.Baker &#x00026; H.G.Sm.) Blakel, <italic>Eucalyptus radiata</italic> subsp. <italic>radiata</italic>, <italic>Eucalyptus radiata</italic> var. <italic>subexserta</italic> Blakely</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Er</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.55</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,8-cineole 48, <italic>p</italic>-cymene 13</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus smithii</italic> R.T. Baker <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus viminalis</italic> var. <italic>pedicellaris</italic> H.Deane &#x00026; Maiden</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Es</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,8-cineole 83</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus urophylla</italic> S. T. Blake <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No synonyms recorded</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eu</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.86</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-phellandrene 45, 1,8-cineole 23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus viminalis</italic> Labill. <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus angustifolia</italic> Desf. ex Link, <italic>Eucalyptus gunnii</italic> Miq., <italic>Eucalyptus huberiana</italic> Naudin, <italic>Eucalyptus viminalis</italic> var. <italic>huberiana</italic> (Naudin) N.T.Burb., <italic>Eucalyptus viminalis</italic> var. <italic>rhynchocorys</italic> Maiden, <italic>Eucalyptus viminalis</italic> subsp. <italic>viminalis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FV</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MEE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1,8-cineole 46, &#x003b1;-pinene 13, &#x003b3;-terpinene 12</td></tr></tbody></table><table-wrap-foot><fn><p>SY: Sampling year, PP: Plant part, CP: Collection place. * Essential oils previously isolated and chemically characterized in <sup>a</sup> Faria et al. [<xref rid="B18-medicines-05-00061" ref-type="bibr">18</xref>], <sup>b</sup> Barbosa et al. [<xref rid="B17-medicines-05-00061" ref-type="bibr">17</xref>] and <sup>c</sup> Sena et al. [<xref rid="B27-medicines-05-00061" ref-type="bibr">27</xref>] (detailed composition of this EO in <xref ref-type="app" rid="app1-medicines-05-00061">Supplementary Table S1</xref>). FV&#x02013;fresh, vegetative-phase aerial parts, MEE: Mata Experimental do Escaroupim arboretum (Salvaterra de Magos, Portugal).</p></fn></table-wrap-foot></table-wrap><table-wrap id="medicines-05-00061-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-05-00061-t002_Table 2</object-id><label>Table 2</label><caption><p>The activity of essential oils of <italic>Corymbia citriodora</italic> and <italic>Eucalyptus</italic> spp. for scavenging ABTS+ and peroxyl radicals.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample Code *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">TEAC (&#x000b5;mol TE/g Essential Oil)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"> ORAC (&#x000b5;mol TE/g Essential Oil)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cc</td><td align="center" valign="middle" rowspan="1" colspan="1">5.08 &#x000b1; 0.08 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">148.55 &#x000b1; 7.76 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ed</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53 &#x000b1; 0.08 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">96.83 &#x000b1; 7.76 <sup>bc</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Edt</td><td align="center" valign="middle" rowspan="1" colspan="1">1.27 &#x000b1; 0.08 <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">73.31 &#x000b1; 7.76 <sup>c</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eg</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30 &#x000b1; 0.08 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">87.29 &#x000b1; 7.76 <sup>bc</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ep</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17 &#x000b1; 0.08 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">99.70 &#x000b1; 7.76 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Er</td><td align="center" valign="middle" rowspan="1" colspan="1">0.21 &#x000b1; 0.08 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">112.33 &#x000b1; 7.76 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Es</td><td align="center" valign="middle" rowspan="1" colspan="1">0.10 &#x000b1; 0.08 <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">93.66 &#x000b1; 7.76 <sup>bc</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Eu</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68 &#x000b1; 0.08 <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">37.14 &#x000b1; 7.76 <sup>d</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ev</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.62 &#x000b1; 0.08 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">135.80 &#x000b1; 7.76 <sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn><p>* For sample code see <xref rid="medicines-05-00061-t001" ref-type="table">Table 1</xref>. Values in the same column followed by the same letter are not significant by Tukey&#x02019;s multiple range test (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><table-wrap id="medicines-05-00061-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-05-00061-t003_Table 3</object-id><label>Table 3</label><caption><p>The antibacterial activities of <italic>Corymbia citriodora</italic> and <italic>Eucalyptus</italic> spp. EOs expressed as inhibition zones, in mm. Tea tree oil and chloramphenicol were used as references.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Essential Oil</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Microorganism <sup>&#x02020;</sup></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. pneumoniae</italic> D39</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>S. pneumoniae</italic> TIGR 4</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>H. influenza</italic> DSM 9999</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tea tree</td><td align="center" valign="middle" rowspan="1" colspan="1">14.00 &#x000b1; 1.73 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.25 &#x000b1; 1.89 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.75 &#x000b1; 2.36 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>C. citriodora</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">11.33 &#x000b1; 2.03 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.00 &#x000b1; 1.41 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.25 &#x000b1; 0.50 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. dives</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">13.67 &#x000b1; 2.08 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">NI</td><td align="center" valign="middle" rowspan="1" colspan="1">10.00 &#x000b1; 0.81 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. globulus</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">12.00 &#x000b1; 1.73 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.75 &#x000b1; 0.95 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">13.00 &#x000b1; 1.82 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. smithii</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">14.00 &#x000b1; 1.73 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">8.00 &#x000b1; 0.81 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">12.00 &#x000b1; 2.16 <sup>a</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>E. viminalis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">14.66 &#x000b1; 1.52 <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">6.66 &#x000b1; 0.57 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">11.75 &#x000b1; 1.50 <sup>a</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloramphenicol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.33 &#x000b1; 4.04 <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.00 &#x000b1; 1.15 <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.00 &#x000b1; 0.81 <sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn><p><bold><sup>&#x02020;</sup></bold> Data represent the mean &#x000b1; standard deviation of three replicates. Data with the same superscript letter are not significantly different (<italic>p</italic> &#x0003e; 0.05). NI: No inhibition.</p></fn></table-wrap-foot></table-wrap><table-wrap id="medicines-05-00061-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">medicines-05-00061-t004_Table 4</object-id><label>Table 4</label><caption><p>Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values for <italic>Eucalyptus</italic> and tea tree EOs <sup>&#x000a7;</sup>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Microorganism</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Tea Tree</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">
<italic>E. globulus</italic>
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">
<italic>E. smithii</italic>
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC <sup>&#x02020;</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MBC <sup>&#x02020;</sup></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MBC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIC</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MBC</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. pneumoniae</italic> D39</td><td align="center" valign="middle" rowspan="1" colspan="1">0.025</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.30</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic>S. pneumoniae</italic> TIGR 4</td><td align="center" valign="middle" rowspan="1" colspan="1">0.025</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>H. influenza</italic> DSM 9999</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;0.4</td></tr></tbody></table><table-wrap-foot><fn><p><sup>&#x000a7;</sup> Data represent the mean of three independent experiments. <bold><sup>&#x02020;</sup></bold> mg/mL.</p></fn></table-wrap-foot></table-wrap></floats-group></article>